Distinct cellular distribution of GABA(B)R1 and GABA(A)α1 receptor immunoreactivity in the rat substantia nigra

Neuroscience

Volumn 99, Issue 1, 2000, Pages 65-76

  Ng, T K Y ^a   Yung, K K L ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Basal ganglia; Confocal microscopy; Dopaminergic neurons; Double and triple immunofluorescence; GABAergic neurons; Parvalbumin

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT; TYROSINE 3 MONOOXYGENASE;

ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; RECEPTOR DENSITY; SUBSTANTIA NIGRA;

ANIMALS; FEMALE; NEURONS; PARVALBUMINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; RECEPTORS, GABA-B; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 0034718191     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00156-1     Document Type: Article

References (44)

1. B receptor isoforms GBR1a and GBR1b, appear to be associated with pre- and post-synaptic elements respectively in rat and human cerebellum. Br. J. Pharmac. 126:1999;1387-1392.
2. Bolam J. P. and Bennett B. D. (1995) Microcircuitry of the neostriatum. In Molecular and Cellular Mechanisms of Neostriatal Function (eds Ariano M. A. and Surmeier P. J.). R. G. Landes, Austin.
3. B receptor pharmacology. A. Rev. Pharmac. Toxicol. 33:1993;109-147.
4. Bowery N.G., Hill D.R., Hudson A.L. Characteristics of GABAB receptor binding sites on rat whole brain synaptic membranes. 1983. Br. J. Pharmac. 120:1997;452-467.
5. B receptors in rat substantia nigra pars reticulata neurones. Eur. J. Pharmac. 349:1998;187-197.
6. Chan P.K., Yung W.H. Inhibitory postsynaptic currents of rat substantia nigra pars reticulata neurons: role of GABA receptors and GABA uptake. Brain Res. 838:1999;18-26.
7. B receptors in the basal ganglia in monkeys. Neuroscience. 95:2000;127-140.
8. B receptors in pars reticulata of the rat substantia nigra. Eur. J. Pharmac. 150:1988;277-286.
9. B receptor splice variants GB1a and GB1b in rat brain: developmental regulation, cellular distribution and extrasynaptic localization. Eur. J. Neurosci. 11:1999;761-768.
10. A-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. comp. Neurol. 359:1995;154-194.
11. Gerfen C. R. and Wilson C. J. (1996) The basal ganglia. In Handbook of Chemical Neuroanatomy. Integrated Systems of the CNS Part 3 (eds Swanson L. W., Björklund A. and Hölfelt T.), Vol. 12, pp. 371-468. Elsevier, Amsterdam.
12. Hardman C.D., McRitchie D.A., Halliday G.M., Cartwright H.R., Morris J.G. Substantia nigra pars reticulata neurons in Parkinson's disease. Neurodegeneration. 5:1996;49-55.
13. Hausser M.A., Yung W.H. Inhibitory synaptic potentials in guinea-pig substantia nigra dopamine neurones in vitro. J. Physiol., Lond. 479 (Pt 3):1994;401-422.
14. Hollrigel G.S., Toth K., Soltesz I. Neuroprotection by propofol in acute mechanical injury: role of GABAergic inhibition. J. Neurophysiol. 76:1996;2412-2422.
15. Hontanilla B., Parent A., de las H.S., Gimenez-Amaya J.M. Distribution of calbindin D-28k and parvalbumin neurons and fibers in the rat basal ganglia. Brain Res. Bull. 47:1998;107-116.
16. Hontanilla B., Parent A., Gimenez-Amaya J.M. Parvalbumin and calbindin D-28k in the entopeduncular nucleus, subthalamic nucleus, and substantia nigra of the rat as revealed by double-immunohistochemical methods. Synapse. 25:1997;359-367.
17. Inglefield J.R., Wilson C.A., Schwartz-Bloom R.D. Effect of transient cerebral ischemia on gamma-aminobutyric acidA receptor alpha 1-subunit-immunoreactive interneurons in the gerbil CA1 hippocampus. Hippocampus. 7:1997;511-523.
18. BR2. Nature. 396:1998;674-679.
19. B receptors uncovers similarity to metabotropic glutamate receptors. Nature. 386:1997;239-246.
20. B receptor subtypes assemble into functional heteromeric complexes. Nature. 396:1998;683-687.
21. B receptor function. Science. 283:1999;74-77.
22. A-receptor subtypes differing in alpha-subunit composition display unique pharmacological properties. Adv. Biochem. Psychopharmac. 47:1992;41-53.
23. A receptors. From subunits to diverse functions. Ion Channels. 4:1996;89-113.
24. A-receptors: cell-specific expression, pharmacology, and regulation. Neurochem. Res. 20:1995;631-636.
25. A/benzodiazepine receptors in the substantia nigra of the rat. Neuroscience. 50:1992;355-370.
26. A receptor changes in the substantia nigra of the rat following quinolinic acid lesions in the striatum closely resemble Huntington's disease. Neuroscience. 66:1995;507-521.
27. A receptor subtype changes in the substantia nigra of the rat following quinolinate lesions in the striatum: a correlative in situ hybridization and immunohistochemical study. Neuroscience. 74:1996;89-98.
28. Paladini C.A., Celada P., Tepper J.M. Striatal, pallidal, and pars reticulata evoked inhibition of nigrostriatal dopaminergic neurons is mediated by GABA(A) receptors in vivo. Neuroscience. 89:1999;799-812.
29. Paladini C.A., Tepper J.M. GABA(A) and GABA(B) antagonists differentially affect the firing pattern of substantia nigra dopaminergic neurons in vivo. Synapse. 32:1999;165-176.
30. Rajakumar N., Elisevich K., Flumerfelt B.A. Parvalbumin-containing GABAergic neurons in the basal ganglia output system of the rat. J. comp. Neurol. 350:1994;324-336.
31. B, receptors in vitro. Brain Res. 659:1994;133-137.
32. Schwartz R.D., Yu X., Katzman M.R., Hayden-Hixson D.M., Perry J.M. Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum. J. Neurosci. 15:1995;529-539.
33. Smith A.D., Bolam J.P. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci. 13:1990;259-265.
34. Smith Y., Bevan M.D., Shink E., Bolam J.P. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience. 86:1998;353-387.
35. Stefani A., Spadoni F., Giacomini P., Lavaroni F., Bernardi G. The modulation of calcium current by GABA metabotropic receptors in a sub-population of pallidal neurons. Eur. J. Neurosci. 11:1999;3995-4005.
36. A receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons. J. Neurosci. 15:1995;3092-3103.
37. Tepper J.M., Paladini C.A., Celada P. GABAergic control of the firing pattern of substantia nigra dopaminergic neurons. Adv. Pharmac. 42:1998;694-699.
38. Tse Y.C., Yung K.K.L. Cellular expression of ionotropic glutamate receptor subunits in subpopulations of neurons in the rat substantia nigra pars reticulata. Brain Res. 854:2000;57-69.
39. B receptor. Nature. 396:1998;679-682.
40. BR1 receptor immunoreactivity. Brain Res. 830:1999;345-352.
41. Yung K.K.L. Localization of ionotropic and metabotropic glutamate receptors in distinct neuronal elements of the rat substantia nigra. Neurochem. Int. 33:1998;313-326.
42. Yung K.K.L., Kwok K.H.H., Gao Z.G., Choi S.Y., Kwok F.S. Expression of GABA transaminase immunoreactivity in interneurons of the rat neostriatum. Neurochem. Int. 33:1999;567-572.
43. Yung K.K.L., Tse Y.C., Gao Z.G., Choi S.Y., Kwok F.S. Localization of GABA transaminase immunoreactivity in the rat substantia nigra pars reticulata. Neurosci. Lett. 253:1998;57-60.
44. Yurek D.M., Sladek J.R. Dopamine cell replacement: Parkinson's disease. A. Rev. Neurosci. 13:1990;415-440.